Persistence of influenza vaccine-induced antibodies in lung transplant patients between seasons

Transplant Infectious Disease

Volumn 13, Issue 5, 2011, Pages 466-470

  Moran, J M ^a   Rose, W E ^a   Darga, A J ^a   Rohde, K A ^a   Hayney, M S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Antibody; Immunosuppression; Influenza vaccine; Lung transplantation; Persistence; Waning

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INFLUENZA VACCINE; INFLUENZA VIRUS ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; TACROLIMUS; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEMAGGLUTINATION; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEASON; SINGLE DRUG DOSE;

ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; SEASONS; TIME FACTORS;

EID: 80053609773     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2011.00654.x     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2005; 54 (RR-8): 1-40.
2. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2006; 55 (RR-10): 1-41.
3. Skowronski D, Tweed S, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis 2008; 197: 490-502.
4. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59 (RR-8): 1-61.
5. Gross PA, Russo C, Teplitzky M, Dran S, Cataruozolo P, Munk G. Time to peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol 1996; 3 (3): 361-362.
6. Food and Drug Administration. Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines. Rockville, MD: Food and Drug Administration, 2007.
7. Centers for Disease Control. Advanced laboratory techniques for influenza diagnosis. Atlanta, GA: Public Health Service, 1975.
8. Hayney MS, Welter DL, Francois M, Reynolds AM, Love RB. Influenza vaccine antibody responses in lung transplant patients. Prog Transplant 2004; 14: 346-351.
9. Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Schilz RJ, Maurer JR. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 2001; 18: 971-976.
10. Powers DC, Belshe RB. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993; 167: 584-592.
11. Powers DC, Hanscome PJ, Pietrobon PJ. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant. Vaccine 1995; 13 (14): 1330-1335.
12. Dopp JM, Wiegert NA, Moran JJM, et al. Effect of annual influenza immunization on antibody response in lung transplant patients. Prog Transplant 2009; 19 (2): 153-159.
13. Song JY, Cheong HJ, Hwang IS, et al. Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence. Vaccine 2010; 28 (23): 3929-3935.